arrow
A

Adelina Orellana

ACE Alzheimer Center Barcelona
H指数:35
被引数:9,414

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761

单中心开放标签、随机、平行组对照临床试验,研究EGb 761治疗对轻度认知障碍患者炎症和神经退行性变血液标志物的长期效果:ACE-2020-EGb 761

2026-09-290
PRE
A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology

一种微创的干血斑生物标志物检测方法,用于检测阿尔茨海默病的病理学

2026-01-050
OAAI
Associations of lifestyle factors with amyloid pathology in persons without dementia

生活方式因素与无痴呆人群淀粉样蛋白病理的相关性

2025-11-130
OA
Cerebrospinal fluid proteomic signatures in cognitively normal individuals identify distinct clusters linked to neurodegeneration

认知正常个体脑脊液蛋白质组学特征可识别与神经退行性变相关的不同集群

2025-10-140
PRE
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
2025-03-250
OAAI
Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia
2024-12-010
OAAI
Amyloid deposition in adults with drug-resistant temporal lobe epilepsy
2024-10-150
PRE
Clinical value of plasma pTau181 to predict Alzheimer's ' s disease pathology in a large real-world cohort of a memory clinic

血浆pTau181在记忆诊所大型真实队列中预测阿尔茨海默病病理的临床价值

2024-10-010
OAAI
Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment
2024-07-302
OAAI
An Insertion Within SIRPβ1 Shows a Dual Effect Over Alzheimer's Disease Cognitive Decline Altering the Microglial Response

SIRPβ1内的插入显示出对阿尔茨海默氏病认知下降的双重作用,改变了小胶质细胞的反应

2024-03-191
PRE
Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition
2024-01-123
OAAI
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease
2024-01-0311
OAAI
Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
2023-09-076
OAAI
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
2023-04-0312
OAAI
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer's disease in individuals with mild cognitive impairment: The NORFACE cohort
2023-02-235
OAAI
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
2023-01-106
OAAI
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers
2022-09-0649
OAAI
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging

一种基于PET成像验证的实用,数据驱动的方法来确定阿尔茨海默病CSF生物标志物的临界值

2022-08-168
OAAI